BCL-2 Inhibitor [EPC] class drugs

1 result
  • venclexta - venetoclax

    (Venetoclax)
    Abbvie Inc.
    Venclexta treats adult CLL or SLL patients, and newly diagnosed AML in adults 75+ or with comorbidities preventing intensive chemotherapy, used in combination with azacitidine, decitabine, or low-dose cytarabine.